Monogenic diabetes mellitus in cystic fibrosis.
Adolescent
Child
Cystic Fibrosis
/ complications
Cystic Fibrosis Transmembrane Conductance Regulator
/ genetics
Diabetes Mellitus, Type 1
/ complications
Female
Frameshift Mutation
/ genetics
Gliclazide
/ therapeutic use
Hepatocyte Nuclear Factor 1-alpha
/ genetics
Humans
Hypoglycemic Agents
/ therapeutic use
Insulin
/ therapeutic use
Male
Siblings
Treatment Outcome
cystic fibrosis
diabetes
endocrinology
paediatric practice
respiratory
Journal
Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
30
08
2018
revised:
13
09
2018
accepted:
15
09
2018
pubmed:
1
10
2018
medline:
17
3
2020
entrez:
1
10
2018
Statut:
ppublish
Résumé
We present a non-consanguineous family of three siblings who presented with diabetes mellitus (DM), two of whom had genetically confirmed cystic fibrosis (CF), with one pancreatic-sufficient mutation in the cystic fibrosis transmembrane conductance regulator (
Identifiants
pubmed: 30269055
pii: archdischild-2018-316141
doi: 10.1136/archdischild-2018-316141
doi:
Substances chimiques
CFTR protein, human
0
HNF1A protein, human
0
Hepatocyte Nuclear Factor 1-alpha
0
Hypoglycemic Agents
0
Insulin
0
Cystic Fibrosis Transmembrane Conductance Regulator
126880-72-6
Gliclazide
G4PX8C4HKV
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
887-889Informations de copyright
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.